iRhythm Technologies (IRTC) Financials

$100.75 -2.45 (-2.37%)

Closing price 04:00 PM Eastern

Extended Trading

$100.98 +0.23 (+0.23%)

As of 04:56 PM Eastern

Annual Income Statements for iRhythm Technologies

This table shows iRhythm Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-23	-21	-30	-50	-55	-44	-101	-116	-123	-113
Consolidated Net Income / (Loss)	-23	-21	-30	-50	-55	-44	-101	-116	-123	-113
Net Income / (Loss) Continuing Operations	-23	-21	-30	-50	-55	-44	-101	-116	-123	-113
Total Pre-Tax Income	-23	-21	-30	-50	-55	-44	-101	-116	-123	-113
Total Operating Income	-22	-16	-28	-46	-55	-44	-100	-114	-125	-116
Total Gross Profit	21	43	71	108	162	195	214	282	332	408
Total Revenue	36	64	99	147	215	265	323	411	493	592
Operating Revenue	36	64	99	147	215	265	323	411	493	592
Total Cost of Revenue	15	21	28	39	52	70	109	129	161	184
Operating Cost of Revenue	15	21	28	39	52	70	109	129	161	184
Total Operating Expenses	43	59	99	154	217	239	314	395	457	523
Selling, General & Admin Expense	37	52	85	133	180	197	275	322	386	419
Research & Development Expense	6.35	7.15	13	21	37	41	39	47	60	104
Restructuring Charge	-	-	-	-	-	-	0.00	27	11	0.64
Total Other Income / (Expense), net	-1.06	-5.32	-2.15	-4.64	0.25	0.07	-1.05	-2.10	2.51	2.78
Interest Expense	1.06	3.25	3.39	6.14	1.64	1.52	1.17	4.14	3.65	20
Interest & Investment Income	-	-	-	-	-	-	-	2.35	6.35	22
Other Income / (Expense), net	-	-2.07	1.24	1.50	1.90	1.59	0.12	-0.31	-0.20	1.25
Income Tax Expense	-	0.00	0.00	0.04	0.07	0.23	0.37	0.27	0.75	0.57
Basic Earnings per Share	($16.57)	($3.95)	($1.31)	($2.11)	($2.16)	($1.58)	($3.46)	($3.88)	($4.04)	($3.63)
Weighted Average Basic Shares Outstanding	1.38M	5.29M	22.63M	23.89M	25.27M	27.75M	29.33M	29.92M	30.53M	31.20M
Diluted Earnings per Share	($16.57)	($3.95)	($1.31)	($2.11)	($2.16)	($1.58)	($3.46)	($3.88)	($4.04)	($3.63)
Weighted Average Diluted Shares Outstanding	1.38M	5.29M	22.63M	23.89M	25.27M	27.75M	29.33M	29.92M	30.53M	31.20M
Weighted Average Basic & Diluted Shares Outstanding	1.38M	5.29M	22.63M	23.89M	25.27M	27.75M	29.51M	30.22M	30.98M	31.41M

This table shows iRhythm Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-21	-20	-39	-18	-27	-39	-46	-20	-46	-1.33
Consolidated Net Income / (Loss)	-21	-20	-39	-18	-27	-39	-46	-20	-46	-1.33
Net Income / (Loss) Continuing Operations	-21	-20	-39	-18	-27	-39	-46	-20	-46	-1.33
Total Pre-Tax Income	-21	-20	-39	-18	-27	-38	-46	-20	-46	-1.18
Total Operating Income	-21	-21	-40	-19	-28	-39	-38	-23	-50	-4.08
Total Gross Profit	71	79	76	86	82	87	88	103	101	115
Total Revenue	104	113	111	124	125	133	132	148	148	164
Operating Revenue	104	113	111	124	125	133	132	148	148	164
Total Cost of Revenue	33	34	36	38	42	45	44	45	46	49
Operating Cost of Revenue	33	34	36	38	42	45	44	45	46	49
Total Operating Expenses	92	99	115	105	110	127	126	126	152	119
Selling, General & Admin Expense	81	87	100	91	94	100	109	107	103	100
Research & Development Expense	11	13	15	14	16	15	17	20	48	19
Total Other Income / (Expense), net	-0.25	0.57	0.48	0.60	0.68	0.74	-7.50	3.07	4.31	2.90
Interest Expense	0.61	1.01	0.95	0.83	0.93	0.94	10	3.31	3.33	3.32
Other Income / (Expense), net	-	-	1.43	1.44	-0.11	-2.96	2.95	6.38	1.18	-9.26
Income Tax Expense	0.12	0.07	0.09	0.21	0.20	0.26	0.03	0.19	0.19	0.15
Basic Earnings per Share	($0.71)	($0.66)	($1.29)	($0.61)	($0.89)	($1.25)	($1.47)	($0.65)	($1.48)	($0.03)
Weighted Average Basic Shares Outstanding	30.06M	29.92M	30.30M	30.50M	30.61M	30.53M	31.03M	31.15M	31.26M	31.20M
Diluted Earnings per Share	($0.71)	($0.66)	($1.29)	($0.61)	($0.89)	($1.25)	($1.47)	($0.65)	($1.48)	($0.03)
Weighted Average Diluted Shares Outstanding	30.06M	29.92M	30.30M	30.50M	30.61M	30.53M	31.03M	31.15M	31.26M	31.20M
Weighted Average Basic & Diluted Shares Outstanding	30.11M	30.22M	30.47M	30.58M	30.65M	30.98M	31.10M	31.24M	31.30M	31.41M

This table details how cash moves in and out of iRhythm Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2021	2022	2023	2024
Net Change in Cash & Equivalents	17	26	-43	11	0.44	39	-49	-43	392
Net Cash From Operating Activities	-18	-17	-15	-29	-22	-38	-23	-50	3.39
Net Cash From Continuing Operating Activities	-18	-17	-15	-29	-22	-38	-23	-50	3.39
Net Income / (Loss) Continuing Operations	-23	-21	-30	-50	-55	-101	-116	-123	-113
Consolidated Net Income / (Loss)	-23	-21	-30	-50	-55	-101	-116	-123	-113
Depreciation Expense	0.49	0.57	1.60	2.27	3.45	9.84	13	16	21
Amortization Expense	0.12	0.26	-0.09	-0.70	8.11	8.39	5.77	0.77	6.51
Non-Cash Adjustments To Reconcile Net Income	3.02	10	21	33	51	92	136	152	180
Changes in Operating Assets and Liabilities, net	1.16	-6.73	-7.21	-13	-30	-46	-62	-96	-91
Net Cash From Investing Activities	-1.79	-68	-35	34	-89	105	-52	-1.21	-123
Net Cash From Continuing Investing Activities	-1.79	-68	-35	34	-89	105	-52	-1.21	-123
Purchase of Property, Plant & Equipment	-1.79	-2.76	-3.56	-5.18	-20	-28	-30	-40	-34
Acquisitions	-	-	-	-	-	-	0.00	0.00	-15
Purchase of Investments	-	-65	-130	-93	-166	-122	-189	-167	-175
Sale and/or Maturity of Investments	-	-	99	132	97	256	166	207	101
Net Cash From Financing Activities	36	111	6.53	6.30	112	-29	27	8.82	511
Net Cash From Continuing Financing Activities	36	111	6.53	6.30	112	-29	27	8.82	511
Repayment of Debt	-4.91	-	0.00	-34	0.00	-12	-21	0.00	-136
Repurchase of Common Equity	-	-	-	-	-	-	0.00	0.00	-25
Issuance of Debt	29	-	0.00	35	-	0.00	35	0.00	736
Issuance of Common Equity	-	114	-	9.32	9.50	8.94	13	8.82	8.47
Other Financing Activities, net	0.30	-3.18	6.53	-3.88	102	-26	0.00	0.00	-72
Other Net Changes in Cash	-	-	-	-	-	-	0.00	-0.17	-0.01
Cash Interest Paid	0.34	1.59	1.55	6.07	1.64	1.19	3.32	2.96	6.39
Cash Income Taxes Paid	-	-	-	-	-	0.00	0.29	1.13	0.92

This table details how cash moves in and out of iRhythm Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-30	7.61	-26	8.77	-14	-11	493	30	-31	-100
Net Cash From Operating Activities	3.67	13	-31	-4.57	1.20	-16	-52	12	24	19
Net Cash From Continuing Operating Activities	3.67	13	-31	-4.57	1.20	-16	-52	12	24	19
Net Income / (Loss) Continuing Operations	-21	-20	-39	-18	-27	-39	-46	-20	-46	-1.33
Consolidated Net Income / (Loss)	-21	-20	-39	-18	-27	-39	-46	-20	-46	-1.33
Depreciation Expense	3.44	3.48	3.58	3.79	4.07	4.91	5.13	5.16	5.14	5.29
Amortization Expense	-3.15	0.69	0.23	0.32	0.08	0.14	0.91	1.75	2.02	1.82
Non-Cash Adjustments To Reconcile Net Income	35	27	40	28	33	51	43	40	64	34
Changes in Operating Assets and Liabilities, net	-10	1.46	-35	-19	-8.98	-33	-55	-15	-0.65	-20
Net Cash From Investing Activities	-35	-8.11	3.82	9.01	-15	1.40	40	15	-55	-122
Net Cash From Continuing Investing Activities	-35	-8.11	3.82	9.01	-15	1.40	40	15	-55	-122
Purchase of Property, Plant & Equipment	-6.33	-7.09	-8.42	-9.40	-9.09	-14	-9.78	-8.49	-8.83	-6.84
Purchase of Investments	-46	-51	-34	-42	-36	-55	-2.43	-15	-40	-118
Sale and/or Maturity of Investments	17	50	46	61	30	70	52	38	8.50	2.50
Net Cash From Financing Activities	1.66	3.15	0.91	4.38	0.07	3.47	505	3.79	-0.04	2.99
Net Cash From Continuing Financing Activities	1.66	3.15	0.91	4.38	0.07	3.47	505	3.79	-0.04	2.99
Issuance of Common Equity	1.66	3.15	0.91	4.38	0.07	3.47	0.60	4.73	0.15	2.99
Other Net Changes in Cash	-	-	0.00	-0.04	0.08	-0.20	-0.00	-0.01	0.01	0.00
Cash Income Taxes Paid	-	0.29	0.01	0.28	0.51	0.34	0.01	0.35	0.24	0.32

This table presents iRhythm Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	38	138	133	118	306	512	463	448	433	931
Total Current Assets	33	119	120	104	173	378	306	289	231	646
Cash & Equivalents	25	52	-	20	20	89	128	79	36	420
Short-Term Investments	-	54	-	58	120	247	112	134	98	116
Accounts Receivable	5.58	9.41	13	20	24	30	46	50	61	80
Inventories, net	1.15	1.39	-	2.06	4.04	5.31	10	15	14	14
Prepaid Expenses	0.81	1.67	-	4.10	4.34	7.36	9.69	11	22	16
Plant, Property, & Equipment, net	2.04	4.65	6.30	9.16	26	34	56	76	104	125
Total Noncurrent Assets	3.01	15	0.00	4.07	107	100	102	84	98	161
Long-Term Investments	-	11	-	0.00	8.03	-	-	-	3.00	62
Goodwill	0.86	0.86	-	0.86	0.86	0.86	0.86	0.86	0.86	0.86
Other Noncurrent Operating Assets	2.15	3.05	-	3.21	98	99	101	83	94	98
Total Liabilities & Shareholders' Equity	38	138	133	118	306	512	463	448	433	931
Total Liabilities	42	46	70	65	171	170	183	208	223	841
Total Current Liabilities	8.78	13	21	30	52	66	88	89	107	111
Accounts Payable	1.46	2.10	-	2.28	8.24	4.37	11	7.52	5.54	7.22
Accrued Expenses	6.70	10	16	27	33	41	51	65	83	85
Current Deferred Revenue	0.51	0.95	-	1.22	1.25	0.93	3.05	3.05	3.31	2.93
Other Current Liabilities	-	-	-	0.00	7.91	8.17	11	13	15	16
Total Noncurrent Liabilities	34	32	54	35	119	104	96	119	116	730
Long-Term Debt	31	32	-	35	33	21	9.69	35	35	646
Other Noncurrent Operating Liabilities	3.05	0.13	54	0.00	86	83	86	84	81	83
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-102	93	-157	52	135	342	280	240	210	91
Total Preferred & Common Equity	-102	93	79	52	135	342	280	240	210	91
Preferred Stock	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-102	93	-157	52	135	342	280	240	210	91
Common Stock	4.64	220	-	258	396	646	686	762	856	875
Retained Earnings	-106	-127	-157	-206	-260	-305	-406	-522	-646	-759
Treasury Stock	-	-	-	-	-	-	-	-	0.00	-25
Accumulated Other Comprehensive Income / (Loss)	-	-0.01	-	-0.02	0.08	0.01	-0.06	-0.40	-0.11	0.17

This table presents iRhythm Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	440	422	429	440	910	919	910
Total Current Assets	286	254	242	234	687	678	628
Cash & Equivalents	71	53	62	47	520	551	520
Short-Term Investments	132	124	103	111	49	11	2.50
Accounts Receivable	61	50	51	50	90	86	77
Inventories, net	14	16	14	14	15	15	15
Prepaid Expenses	7.33	12	12	12	14	15	13
Plant, Property, & Equipment, net	72	82	90	97	112	118	122
Total Noncurrent Assets	83	86	98	109	110	124	159
Long-Term Investments	-	-	-	-	-	-	59
Goodwill	0.86	0.86	0.86	0.86	0.86	0.86	0.86
Other Noncurrent Operating Assets	82	85	97	108	109	123	99
Total Liabilities & Shareholders' Equity	440	422	429	440	910	919	910
Total Liabilities	201	200	206	220	819	820	838
Total Current Liabilities	84	82	89	102	97	98	100
Accounts Payable	7.40	9.78	7.15	7.21	8.44	13	7.59
Accrued Expenses	60	55	64	77	70	66	74
Current Deferred Revenue	3.00	3.49	3.70	3.38	3.07	3.15	3.03
Other Current Liabilities	13	14	14	15	15	15	16
Total Noncurrent Liabilities	118	118	116	118	723	722	738
Long-Term Debt	35	35	35	35	644	645	646
Other Noncurrent Operating Liabilities	83	83	81	83	79	77	92
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	239	222	224	220	90	99	72
Total Preferred & Common Equity	239	222	224	220	90	99	72
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	239	222	224	220	90	99	72
Common Stock	742	783	804	827	807	835	854
Retained Earnings	-502	-561	-580	-607	-691	-711	-758
Treasury Stock	-	-	-	-	-25	-25	-25
Accumulated Other Comprehensive Income / (Loss)	-0.68	-0.07	-0.15	-0.02	-0.09	0.18	-0.07

This table displays calculated financial ratios and metrics derived from iRhythm Technologies' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	66.17%	77.29%	54.72%	48.57%	45.68%	23.59%	21.74%	27.29%	19.90%	20.13%
EBITDA Growth	-45.87%	19.94%	-47.65%	-71.51%	3.07%	30.47%	-184.07%	-16.34%	-14.03%	19.60%
EBIT Growth	-46.50%	18.38%	-49.27%	-67.68%	-19.62%	20.39%	-137.22%	-14.30%	-9.87%	8.86%
NOPAT Growth	-46.50%	27.96%	-77.07%	-65.60%	-19.84%	20.24%	-128.84%	-13.85%	-10.00%	7.71%
Net Income Growth	-44.01%	8.32%	-42.28%	-69.39%	-8.32%	19.68%	-131.26%	-14.60%	-6.24%	8.20%
EPS Growth	-37.51%	76.16%	66.84%	-61.07%	-2.37%	26.85%	-118.99%	-12.14%	-4.12%	10.15%
Operating Cash Flow Growth	-15.22%	7.52%	10.45%	-95.11%	24.85%	37.07%	-174.39%	39.05%	-117.72%	106.77%
Free Cash Flow Firm Growth	0.00%	-11.02%	320.28%	-334.27%	44.00%	5.94%	-91.45%	13.86%	-68.90%	16.25%
Invested Capital Growth	0.00%	817.11%	-761.54%	117.41%	146.39%	81.06%	56.70%	-0.22%	75.78%	29.19%
Revenue Q/Q Growth	0.00%	0.00%	11.34%	9.66%	8.78%	8.03%	0.94%	8.11%	4.21%	5.68%
EBITDA Q/Q Growth	0.00%	0.00%	-24.19%	-1.54%	-5.74%	24.18%	-36.33%	9.74%	-19.61%	21.98%
EBIT Q/Q Growth	0.00%	0.00%	-25.51%	-1.49%	-8.71%	15.29%	-29.74%	8.93%	-17.51%	16.42%
NOPAT Q/Q Growth	0.00%	0.00%	-31.40%	-4.94%	-9.25%	15.72%	-29.25%	9.18%	-17.33%	23.31%
Net Income Q/Q Growth	0.00%	0.00%	-21.20%	-10.53%	-1.92%	14.86%	-29.09%	9.57%	-17.64%	24.80%
EPS Q/Q Growth	0.00%	0.00%	-123.99%	0.00%	0.00%	18.13%	-29.59%	10.39%	-17.10%	25.15%
Operating Cash Flow Q/Q Growth	0.00%	21.85%	-22.97%	-2.29%	-2.28%	47.96%	-123.52%	52.68%	-132.45%	110.66%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-346.99%	52.05%	23.03%	-22.71%	16.28%	-33.86%	22.78%
Invested Capital Q/Q Growth	0.00%	0.00%	-536.34%	115.80%	36.94%	-6.75%	-2.53%	-12.76%	12.48%	2.49%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	59.32%	67.41%	71.55%	73.66%	75.54%	73.50%	66.16%	68.54%	67.35%	68.86%
EBITDA Margin	-58.17%	-26.27%	-25.07%	-28.94%	-19.25%	-10.83%	-25.27%	-23.10%	-21.97%	-14.70%
Operating Margin	-59.85%	-24.32%	-27.83%	-31.02%	-25.52%	-16.47%	-30.96%	-27.69%	-25.40%	-19.52%
EBIT Margin	-59.85%	-27.55%	-26.59%	-30.00%	-24.64%	-15.87%	-30.92%	-27.77%	-25.44%	-19.30%
Profit (Net Income) Margin	-63.09%	-32.62%	-30.00%	-34.21%	-25.43%	-16.53%	-31.40%	-28.27%	-25.05%	-19.14%
Tax Burden Percent	100.48%	100.00%	100.00%	100.09%	100.12%	100.53%	100.36%	100.23%	100.61%	100.50%
Interest Burden Percent	104.90%	118.40%	112.85%	113.90%	103.11%	103.61%	101.17%	101.57%	97.84%	98.66%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-3,622.42%	-256.55%	0.00%	0.00%	-250.57%	-99.97%	-138.34%	-129.15%	-103.14%	-65.16%
ROIC Less NNEP Spread (ROIC-NNEP)	-3,907.92%	-231.42%	0.00%	0.00%	-229.88%	-93.59%	-126.26%	-110.71%	-77.58%	57.64%
Return on Net Nonoperating Assets (RNNOA)	4,629.44%	209.07%	0.00%	0.00%	192.38%	81.59%	105.70%	84.42%	48.28%	-10.12%
Return on Equity (ROE)	1,007.02%	-47.49%	92.59%	96.27%	-58.19%	-18.38%	-32.64%	-44.73%	-54.86%	-75.27%
Cash Return on Invested Capital (CROIC)	-3,822.42%	-417.23%	0.00%	-1,036.41%	-335.09%	-157.65%	-182.52%	-128.93%	-158.10%	-90.63%
Operating Return on Assets (OROA)	-57.12%	-20.06%	-19.41%	-35.22%	-24.95%	-10.29%	-20.48%	-25.04%	-28.45%	-16.75%
Return on Assets (ROA)	-60.20%	-23.75%	-21.91%	-40.16%	-25.76%	-10.72%	-20.80%	-25.50%	-28.00%	-16.60%
Return on Common Equity (ROCE)	22,601.08%	4.89%	92.59%	96.27%	-58.19%	-18.38%	-32.64%	-44.73%	-54.86%	-75.27%
Return on Equity Simple (ROE_SIMPLE)	22.43%	-22.58%	-37.48%	-96.63%	-40.30%	-12.83%	-36.26%	-48.44%	-58.74%	-124.62%
Net Operating Profit after Tax (NOPAT)	-15	-11	-19	-32	-38	-31	-70	-80	-88	-81
NOPAT Margin	-41.90%	-17.02%	-19.48%	-21.72%	-17.86%	-11.53%	-21.67%	-19.38%	-17.78%	-13.66%
Net Nonoperating Expense Percent (NNEP)	285.51%	-25.14%	98.43%	58.60%	-20.69%	-6.38%	-12.08%	-18.44%	-25.56%	-122.80%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-28.99%	-35.75%	-10.97%
Cost of Revenue to Revenue	40.68%	32.59%	28.45%	26.34%	24.46%	26.50%	33.84%	31.46%	32.65%	31.14%
SG&A Expenses to Revenue	101.61%	80.57%	86.00%	90.52%	83.67%	74.38%	85.14%	78.41%	78.27%	70.72%
R&D to Revenue	17.57%	11.16%	13.38%	14.16%	17.38%	15.59%	11.98%	11.34%	12.23%	17.54%
Operating Expenses to Revenue	119.18%	91.73%	99.38%	104.68%	101.06%	89.97%	97.11%	96.23%	92.75%	88.37%
Earnings before Interest and Taxes (EBIT)	-22	-18	-26	-44	-53	-42	-100	-114	-125	-114
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-21	-17	-25	-43	-41	-29	-82	-95	-108	-87
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	7.17	0.00	32.23	13.39	20.05	12.39	11.76	15.62	31.04
Price to Tangible Book Value (P/TBV)	0.00	7.24	0.00	32.77	13.47	20.10	12.43	11.80	15.68	31.34
Price to Revenue (P/Rev)	0.00	10.36	12.99	11.41	8.45	25.83	10.73	6.86	6.66	4.77
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	75.51	0.00	185.32	78.09	166.15	52.56	42.89	29.36	20.52
Enterprise Value to Revenue (EV/Rev)	0.00	9.04	12.99	11.11	7.92	24.69	10.05	6.43	6.45	4.85
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	846.94
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	32.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-6.75	0.35	0.00	0.67	0.26	0.10	0.08	0.15	0.17	7.11
Long-Term Debt to Equity	-6.75	0.35	0.00	0.67	0.24	0.06	0.03	0.15	0.17	7.11
Financial Leverage	-1.18	-0.90	-0.33	-0.60	-0.84	-0.87	-0.84	-0.76	-0.62	-0.18
Leverage Ratio	-8.36	2.00	-4.23	-2.40	2.26	1.71	1.57	1.75	1.96	4.53
Compound Leverage Factor	-8.77	2.37	-4.77	-2.73	2.33	1.78	1.59	1.78	1.92	4.47
Debt to Total Capital	117.40%	25.83%	0.00%	40.10%	20.51%	8.81%	7.10%	12.72%	14.26%	87.67%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	1.14%	3.11%	3.88%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	117.40%	25.83%	0.00%	40.10%	19.37%	5.70%	3.22%	12.72%	14.26%	87.67%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	373.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-390.50%	74.17%	100.00%	59.90%	79.49%	91.19%	92.90%	87.28%	85.74%	12.33%
Debt to EBITDA	-1.45	-1.91	0.00	-0.82	-0.85	-1.15	-0.26	-0.37	-0.32	-7.43
Net Debt to EBITDA	-0.25	5.04	0.00	1.02	2.75	10.52	2.67	1.88	0.94	-0.56
Long-Term Debt to EBITDA	-1.45	-1.91	0.00	-0.82	-0.80	-0.74	-0.12	-0.37	-0.32	-7.43
Debt to NOPAT	-2.02	-2.95	0.00	-1.09	-0.91	-1.08	-0.31	-0.44	-0.40	-8.00
Net Debt to NOPAT	-0.35	7.78	0.00	1.36	2.97	9.89	3.11	2.24	1.16	-0.61
Long-Term Debt to NOPAT	-2.02	-2.95	0.00	-1.09	-0.86	-0.70	-0.14	-0.44	-0.40	-8.00
Altman Z-Score	0.00	8.40	10.35	13.73	5.78	24.30	10.65	7.10	7.26	1.79
Noncontrolling Interest Sharing Ratio	-2,144.35%	110.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.74	8.98	5.60	3.44	3.32	5.75	3.48	3.24	2.15	5.82
Quick Ratio	3.51	8.74	0.61	3.24	3.16	5.56	3.25	2.95	1.82	5.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-16	-18	39	-92	-51	-48	-92	-80	-134	-112
Operating Cash Flow to CapEx	-1,007.55%	-602.64%	-418.61%	-561.64%	-106.87%	-101.53%	-134.51%	-77.14%	-123.94%	9.99%
Free Cash Flow to Firm to Interest Expense	-15.09	-5.46	11.54	-14.90	-31.20	-31.74	-78.96	-19.21	-36.79	-5.51
Operating Cash Flow to Interest Expense	-17.00	-5.13	-4.40	-4.74	-13.31	-9.06	-32.30	-5.56	-13.73	0.17
Operating Cash Flow Less CapEx to Interest Expense	-18.69	-5.98	-5.46	-5.58	-25.76	-17.98	-56.30	-12.77	-24.80	-1.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.95	0.73	0.73	1.17	1.01	0.65	0.66	0.90	1.12	0.87
Accounts Receivable Turnover	6.48	8.55	8.80	8.95	9.83	9.86	8.46	8.53	8.85	8.37
Inventory Turnover	12.84	16.48	0.00	0.00	17.21	15.03	14.02	10.17	11.05	13.16
Fixed Asset Turnover	17.75	19.16	18.11	19.06	12.05	8.74	7.16	6.24	5.48	5.16
Accounts Payable Turnover	10.08	11.73	0.00	0.00	9.97	11.15	14.69	14.34	24.64	28.88
Days Sales Outstanding (DSO)	56.33	42.68	41.50	40.80	37.14	37.03	43.17	42.79	41.27	43.61
Days Inventory Outstanding (DIO)	28.43	22.15	0.00	0.00	21.21	24.28	26.03	35.89	33.04	27.74
Days Payable Outstanding (DPO)	36.23	31.13	0.00	0.00	36.60	32.74	24.84	25.44	14.82	12.64
Cash Conversion Cycle (CCC)	48.53	33.70	41.50	40.80	21.74	28.57	44.35	53.23	59.49	58.71
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.84	7.67	-51	8.83	22	39	62	62	108	140
Invested Capital Turnover	86.46	15.07	-4.61	-7.03	14.03	8.67	6.38	6.66	5.80	4.77
Increase / (Decrease) in Invested Capital	0.84	6.83	-58	60	13	18	22	-0.14	47	32
Enterprise Value (EV)	0.00	579	1,288	1,637	1,699	6,546	3,245	2,642	3,179	2,871
Market Capitalization	0.00	664	1,288	1,680	1,813	6,849	3,463	2,820	3,281	2,822
Book Value per Share	($73.85)	$4.18	($6.82)	$2.16	$5.09	$11.83	$9.50	$7.96	$6.85	$2.90
Tangible Book Value per Share	($74.48)	$4.14	($6.82)	$2.12	$5.05	$11.80	$9.47	$7.94	$6.83	$2.88
Total Capital	26	125	-157	87	170	375	301	275	245	737
Total Debt	31	32	0.00	35	35	33	21	35	35	646
Total Long-Term Debt	31	32	0.00	35	33	21	9.69	35	35	646
Net Debt	5.25	-85	0.00	-43	-114	-302	-218	-178	-102	49
Capital Expenditures (CapEx)	1.79	2.76	3.56	5.18	20	14	28	30	40	34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.25	-0.75	98	-4.38	-18	-11	-9.80	-13	-10	-0.65
Debt-free Net Working Capital (DFNWC)	24	105	98	74	123	324	229	200	123	535
Net Working Capital (NWC)	24	105	98	74	121	312	218	200	123	535
Net Nonoperating Expense (NNE)	7.66	10.00	10	18	16	13	31	37	36	32
Net Nonoperating Obligations (NNO)	5.36	-85	106	-43	-114	-302	-218	-178	-102	49
Total Depreciation and Amortization (D&A)	0.61	0.83	1.51	1.57	12	13	18	19	17	27
Debt-free, Cash-free Net Working Capital to Revenue	-3.44%	-1.17%	99.24%	-2.98%	-8.33%	-4.30%	-3.03%	-3.28%	-2.10%	-0.11%
Debt-free Net Working Capital to Revenue	66.56%	164.49%	99.24%	50.22%	57.18%	122.12%	71.04%	48.59%	25.06%	90.38%
Net Working Capital to Revenue	66.56%	164.49%	99.24%	50.22%	56.27%	117.72%	67.43%	48.59%	25.06%	90.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($16.57)	($3.95)	($1.30)	($2.02)	($2.16)	($1.58)	($3.46)	($3.88)	($4.04)	($3.63)
Adjusted Weighted Average Basic Shares Outstanding	1.38M	22.15M	23.45M	24.46M	26.80M	29.16M	29.33M	29.92M	30.53M	31.20M
Adjusted Diluted Earnings per Share	($16.57)	($3.95)	($1.30)	($2.02)	($2.16)	($1.58)	($3.46)	($3.88)	($4.04)	($3.63)
Adjusted Weighted Average Diluted Shares Outstanding	1.38M	22.15M	23.45M	24.46M	26.80M	29.16M	29.33M	29.92M	30.53M	31.20M
Adjusted Basic & Diluted Earnings per Share	($16.57)	($3.95)	($1.30)	($2.02)	($2.16)	($1.58)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.38M	5.29M	22.63M	23.89M	25.27M	27.75M	29.51M	30.22M	30.98M	31.41M
Normalized Net Operating Profit after Tax (NOPAT)	-15	-11	-19	-32	-38	-31	-70	-61	-80	-80
Normalized NOPAT Margin	-41.90%	-17.02%	-19.48%	-21.72%	-17.86%	-11.53%	-21.67%	-14.85%	-16.21%	-13.59%
Pre Tax Income Margin	-62.78%	-32.62%	-30.00%	-34.18%	-25.40%	-16.44%	-31.28%	-28.20%	-24.90%	-19.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-20.43	-5.44	-7.78	-7.19	-32.17	-27.70	-85.39	-27.57	-34.34	-5.60
NOPAT to Interest Expense	-14.30	-3.36	-5.70	-5.21	-23.33	-20.13	-59.85	-19.25	-24.00	-3.96
EBIT Less CapEx to Interest Expense	-22.11	-6.29	-8.84	-8.04	-44.62	-36.62	-109.40	-34.78	-45.42	-7.26
NOPAT Less CapEx to Interest Expense	-15.99	-4.21	-6.76	-6.05	-35.78	-29.05	-83.86	-26.46	-35.08	-5.62
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-22.07%

This table displays calculated financial ratios and metrics derived from iRhythm Technologies' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	21.59%	37.67%	20.63%	21.64%	19.96%	17.67%	18.39%	19.27%	18.41%	24.01%
EBITDA Growth	-11.98%	38.95%	10.79%	29.31%	-13.31%	-124.33%	14.96%	27.30%	-78.11%	83.20%
EBIT Growth	9.73%	35.69%	21.55%	25.65%	-31.42%	-103.59%	7.58%	4.79%	-77.26%	68.33%
NOPAT Growth	9.43%	35.72%	18.63%	19.53%	-30.91%	-89.30%	3.46%	-21.77%	-82.24%	89.58%
Net Income Growth	9.61%	37.84%	22.72%	22.66%	-26.41%	-91.60%	-16.77%	-8.79%	-70.31%	96.56%
EPS Growth	12.35%	40.54%	24.56%	23.75%	-25.35%	-89.39%	-13.95%	-6.56%	-66.29%	97.60%
Operating Cash Flow Growth	-79.24%	196.40%	20.91%	-1,129.03%	-67.40%	-227.00%	-69.18%	358.97%	1,935.70%	220.41%
Free Cash Flow Firm Growth	41.06%	68.02%	-34.57%	-138.03%	-104.11%	-416.41%	-200.52%	-225.05%	-67.75%	53.48%
Invested Capital Growth	11.48%	-0.22%	13.33%	25.31%	36.32%	75.78%	105.47%	94.20%	41.79%	29.19%
Revenue Q/Q Growth	1.79%	8.42%	-1.05%	11.39%	0.38%	6.35%	-0.44%	12.22%	-0.34%	11.38%
EBITDA Q/Q Growth	-10.30%	20.51%	-106.76%	61.11%	-76.79%	-57.38%	14.61%	66.75%	-333.10%	85.15%
EBIT Q/Q Growth	10.08%	1.84%	-83.94%	54.20%	-58.92%	-52.07%	10.20%	52.82%	-195.89%	72.83%
NOPAT Q/Q Growth	10.08%	1.84%	-90.86%	52.23%	-46.26%	-41.95%	2.66%	39.74%	-118.89%	91.88%
Net Income Q/Q Growth	10.24%	5.84%	-93.63%	52.74%	-46.72%	-42.72%	-18.01%	55.97%	-129.68%	97.11%
EPS Q/Q Growth	11.25%	7.04%	-95.45%	52.71%	-45.90%	-40.45%	-17.60%	55.78%	-127.69%	97.97%
Operating Cash Flow Q/Q Growth	1,086.29%	242.76%	-344.54%	85.13%	126.16%	-1,435.45%	-225.75%	122.76%	105.63%	-21.01%
Free Cash Flow Firm Q/Q Growth	-62.81%	34.87%	-158.62%	13.20%	-39.61%	-64.78%	-44.65%	6.12%	27.95%	54.31%
Invested Capital Q/Q Growth	-5.94%	-12.76%	30.57%	16.97%	2.32%	12.48%	48.52%	10.55%	-25.29%	2.49%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.28%	69.89%	67.91%	69.46%	66.19%	65.98%	66.34%	69.89%	68.78%	70.02%
EBITDA Margin	-20.02%	-14.68%	-30.75%	-10.74%	-18.91%	-27.98%	-22.09%	-6.55%	-28.44%	-3.79%
Operating Margin	-20.30%	-18.38%	-35.45%	-15.20%	-22.15%	-29.57%	-28.91%	-15.52%	-34.09%	-2.48%
EBIT Margin	-20.30%	-18.38%	-34.16%	-14.05%	-22.24%	-31.80%	-26.67%	-11.21%	-33.29%	-8.12%
Profit (Net Income) Margin	-20.65%	-17.94%	-35.10%	-14.89%	-21.76%	-29.20%	-34.61%	-13.58%	-31.30%	-0.81%
Tax Burden Percent	100.54%	100.36%	100.22%	101.17%	100.72%	100.66%	100.07%	100.97%	100.41%	112.78%
Interest Burden Percent	101.18%	97.23%	102.50%	104.77%	97.15%	91.23%	129.70%	119.95%	93.63%	8.86%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-80.64%	-85.72%	-140.94%	-56.88%	-87.86%	-120.05%	-84.53%	-42.17%	-114.84%	-8.30%
ROIC Less NNEP Spread (ROIC-NNEP)	-77.30%	-82.84%	-133.67%	-53.36%	-82.53%	-112.00%	-27.40%	-24.79%	-77.53%	-14.07%
Return on Net Nonoperating Assets (RNNOA)	57.95%	63.16%	90.30%	34.09%	52.52%	69.71%	5.83%	3.55%	15.63%	2.47%
Return on Equity (ROE)	-22.69%	-22.56%	-50.64%	-22.79%	-35.34%	-50.34%	-78.70%	-38.62%	-99.21%	-5.83%
Cash Return on Invested Capital (CROIC)	-141.79%	-128.93%	-109.34%	-105.36%	-120.23%	-158.10%	-139.59%	-128.73%	-125.15%	-90.63%
Operating Return on Assets (OROA)	-16.76%	-16.58%	-34.55%	-14.68%	-23.89%	-35.55%	-20.56%	-8.93%	-27.63%	-7.04%
Return on Assets (ROA)	-17.05%	-16.18%	-35.49%	-15.56%	-23.38%	-32.65%	-26.68%	-10.82%	-25.98%	-0.70%
Return on Common Equity (ROCE)	-22.69%	-22.56%	-50.64%	-22.79%	-35.34%	-50.34%	-78.70%	-38.62%	-99.21%	-5.83%
Return on Equity Simple (ROE_SIMPLE)	-53.69%	0.00%	-47.18%	-44.33%	-47.73%	0.00%	-143.94%	-132.66%	-209.93%	0.00%
Net Operating Profit after Tax (NOPAT)	-15	-14	-28	-13	-19	-27	-27	-16	-35	-2.86
NOPAT Margin	-14.21%	-12.87%	-24.82%	-10.64%	-15.51%	-20.70%	-20.24%	-10.87%	-23.87%	-1.74%
Net Nonoperating Expense Percent (NNEP)	-3.34%	-2.88%	-7.27%	-3.52%	-5.34%	-8.05%	-57.13%	-17.37%	-37.32%	5.77%
Return On Investment Capital (ROIC_SIMPLE)	-	-5.27%	-	-	-	-11.19%	-	-	-	-0.39%
Cost of Revenue to Revenue	31.72%	30.11%	32.09%	30.54%	33.81%	34.02%	33.66%	30.11%	31.22%	29.98%
SG&A Expenses to Revenue	77.55%	77.01%	90.05%	73.65%	75.25%	75.55%	82.36%	72.11%	70.07%	60.71%
R&D to Revenue	11.02%	11.26%	13.32%	11.02%	13.09%	11.63%	12.88%	13.30%	32.37%	11.80%
Operating Expenses to Revenue	88.57%	88.27%	103.36%	84.67%	88.34%	95.55%	95.24%	85.41%	102.87%	72.51%
Earnings before Interest and Taxes (EBIT)	-21	-21	-38	-17	-28	-42	-35	-17	-49	-13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-21	-17	-34	-13	-24	-37	-29	-9.69	-42	-6.23
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	15.72	11.76	16.89	14.20	13.11	15.62	39.38	33.76	32.31	31.04
Price to Tangible Book Value (P/TBV)	15.78	11.80	16.96	14.25	13.16	15.68	39.76	34.05	32.71	31.34
Price to Revenue (P/Rev)	9.90	6.86	8.72	7.03	6.10	6.66	6.93	6.23	4.14	4.77
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	50.88	42.89	44.83	32.41	28.66	29.36	21.97	18.78	17.46	20.52
Enterprise Value to Revenue (EV/Rev)	9.45	6.43	8.39	6.74	5.84	6.45	7.07	6.39	4.26	4.85
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	846.94
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.15	0.15	0.16	0.16	0.16	0.17	7.13	6.50	9.00	7.11
Long-Term Debt to Equity	0.15	0.15	0.16	0.16	0.16	0.17	7.13	6.50	9.00	7.11
Financial Leverage	-0.75	-0.76	-0.68	-0.64	-0.64	-0.62	-0.21	-0.14	-0.20	-0.18
Leverage Ratio	1.72	1.75	1.82	1.85	1.92	1.96	4.27	4.17	4.63	4.53
Compound Leverage Factor	1.74	1.71	1.87	1.93	1.86	1.79	5.53	5.01	4.33	0.40
Debt to Total Capital	12.74%	12.72%	13.61%	13.50%	13.72%	14.26%	87.71%	86.67%	90.00%	87.67%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	12.74%	12.72%	13.61%	13.50%	13.72%	14.26%	87.71%	86.67%	90.00%	87.67%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.26%	87.28%	86.39%	86.50%	86.28%	85.74%	12.30%	13.33%	10.00%	12.33%
Debt to EBITDA	-0.33	-0.37	-0.39	-0.40	-0.39	-0.32	-6.66	-6.93	-5.79	-7.43
Net Debt to EBITDA	1.60	1.88	1.60	1.48	1.37	0.94	-0.77	-0.90	-0.58	-0.56
Long-Term Debt to EBITDA	-0.33	-0.37	-0.39	-0.40	-0.39	-0.32	-6.66	-6.93	-5.79	-7.43
Debt to NOPAT	-0.40	-0.44	-0.48	-0.50	-0.47	-0.40	-7.43	-7.20	-6.13	-8.00
Net Debt to NOPAT	1.92	2.24	1.93	1.85	1.65	1.16	-0.87	-0.93	-0.61	-0.61
Long-Term Debt to NOPAT	-0.40	-0.44	-0.48	-0.50	-0.47	-0.40	-7.43	-7.20	-6.13	-8.00
Altman Z-Score	10.88	7.79	10.60	8.73	7.16	7.90	2.76	2.65	1.63	2.15
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.42	3.24	3.10	2.71	2.29	2.15	7.10	6.92	6.27	5.82
Quick Ratio	3.16	2.95	2.76	2.41	2.04	1.82	6.80	6.61	5.99	5.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-22	-14	-37	-32	-45	-74	-112	-105	-75	-34
Operating Cash Flow to CapEx	57.93%	177.30%	-365.11%	-48.65%	13.16%	-118.16%	-532.21%	139.49%	275.61%	281.01%
Free Cash Flow to Firm to Interest Expense	-35.89	-14.17	-39.07	-38.72	-48.51	-78.75	-10.67	-31.62	-22.66	-10.38
Operating Cash Flow to Interest Expense	5.98	12.41	-32.37	-5.50	1.29	-16.97	-4.98	3.57	7.31	5.79
Operating Cash Flow Less CapEx to Interest Expense	-4.34	5.41	-41.24	-16.79	-8.51	-31.34	-5.91	1.01	4.66	3.73
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.83	0.90	1.01	1.05	1.07	1.12	0.77	0.80	0.83	0.87
Accounts Receivable Turnover	6.71	8.53	8.20	8.33	8.55	8.85	7.37	7.86	8.79	8.37
Inventory Turnover	10.31	10.17	9.32	9.72	10.65	11.05	10.85	11.79	12.56	13.16
Fixed Asset Turnover	6.08	6.24	6.17	5.80	5.62	5.48	5.28	5.18	5.11	5.16
Accounts Payable Turnover	20.48	14.34	17.70	21.39	20.48	24.64	18.61	17.13	24.33	28.88
Days Sales Outstanding (DSO)	54.42	42.79	44.50	43.80	42.69	41.27	49.53	46.42	41.55	43.61
Days Inventory Outstanding (DIO)	35.39	35.89	39.15	37.53	34.26	33.04	33.65	30.97	29.06	27.74
Days Payable Outstanding (DPO)	17.83	25.44	20.62	17.06	17.82	14.82	19.61	21.31	15.00	12.64
Cash Conversion Cycle (CCC)	71.99	53.23	63.02	64.27	59.13	59.49	63.57	56.08	55.60	58.71
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	71	62	80	94	96	108	165	183	136	140
Invested Capital Turnover	5.67	6.66	5.68	5.34	5.67	5.80	4.18	3.88	4.81	4.77
Increase / (Decrease) in Invested Capital	7.27	-0.14	9.46	19	26	47	85	89	40	32
Enterprise Value (EV)	3,593	2,642	3,606	3,049	2,759	3,179	3,630	3,432	2,384	2,871
Market Capitalization	3,762	2,820	3,748	3,179	2,882	3,281	3,555	3,348	2,319	2,822
Book Value per Share	$7.97	$7.96	$7.34	$7.35	$7.19	$6.85	$2.91	$3.19	$2.30	$2.90
Tangible Book Value per Share	$7.94	$7.94	$7.31	$7.32	$7.16	$6.83	$2.88	$3.16	$2.27	$2.88
Total Capital	274	275	257	259	255	245	734	744	718	737
Total Debt	35	35	35	35	35	35	644	645	646	646
Total Long-Term Debt	35	35	35	35	35	35	644	645	646	646
Net Debt	-169	-178	-141	-130	-124	-102	75	84	65	49
Capital Expenditures (CapEx)	6.33	7.09	8.42	9.40	9.09	14	9.78	8.49	8.83	6.84
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.28	-13	-4.35	-12	-26	-10	22	18	5.77	-0.65
Debt-free Net Working Capital (DFNWC)	202	200	172	153	132	123	591	580	528	535
Net Working Capital (NWC)	202	200	172	153	132	123	591	580	528	535
Net Nonoperating Expense (NNE)	6.69	5.71	11	5.27	7.79	11	19	4.02	11	-1.53
Net Nonoperating Obligations (NNO)	-169	-178	-141	-130	-124	-102	75	84	65	49
Total Depreciation and Amortization (D&A)	0.29	4.17	3.80	4.11	4.15	5.06	6.05	6.91	7.15	7.11
Debt-free, Cash-free Net Working Capital to Revenue	-0.34%	-3.28%	-1.01%	-2.66%	-5.60%	-2.10%	4.19%	3.38%	1.03%	-0.11%
Debt-free Net Working Capital to Revenue	53.21%	48.59%	40.00%	33.79%	27.92%	25.06%	115.09%	107.92%	94.25%	90.38%
Net Working Capital to Revenue	53.21%	48.59%	40.00%	33.79%	27.92%	25.06%	115.09%	107.92%	94.25%	90.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.71)	($0.66)	($1.29)	($0.61)	($0.89)	($1.25)	($1.47)	($0.65)	($1.48)	($0.03)
Adjusted Weighted Average Basic Shares Outstanding	30.06M	29.92M	30.30M	30.50M	30.61M	30.53M	31.03M	31.15M	31.26M	31.20M
Adjusted Diluted Earnings per Share	($0.71)	($0.66)	($1.29)	($0.61)	($0.89)	($1.25)	($1.47)	($0.65)	($1.48)	($0.03)
Adjusted Weighted Average Diluted Shares Outstanding	30.06M	29.92M	30.30M	30.50M	30.61M	30.53M	31.03M	31.15M	31.26M	31.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	30.11M	30.22M	30.47M	30.58M	30.65M	30.98M	31.10M	31.24M	31.30M	31.41M
Normalized Net Operating Profit after Tax (NOPAT)	-15	-14	-28	-13	-19	-27	-27	-16	-35	-2.86
Normalized NOPAT Margin	-14.21%	-12.87%	-24.82%	-10.64%	-15.51%	-20.70%	-20.24%	-10.87%	-23.56%	-1.74%
Pre Tax Income Margin	-20.54%	-17.87%	-35.02%	-14.72%	-21.61%	-29.01%	-34.59%	-13.45%	-31.17%	-0.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-34.34	-20.43	-40.08	-20.96	-29.89	-44.78	-3.37	-5.01	-14.76	-4.02
NOPAT to Interest Expense	-24.04	-14.30	-29.11	-15.88	-20.84	-29.15	-2.55	-4.86	-10.58	-0.86
EBIT Less CapEx to Interest Expense	-44.66	-27.43	-48.94	-32.25	-39.70	-59.15	-4.30	-7.58	-17.41	-6.08
NOPAT Less CapEx to Interest Expense	-34.35	-21.30	-37.97	-27.17	-30.65	-43.51	-3.49	-7.42	-13.23	-2.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-22.07%

Frequently Asked Questions About iRhythm Technologies' Financials

When does iRhythm Technologies's fiscal year end?

According to the most recent income statement we have on file, iRhythm Technologies' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has iRhythm Technologies' net income changed over the last 9 years?

iRhythm Technologies' net income appears to be on an upward trend, with a most recent value of -$113.29 million in 2024, rising from -$22.80 million in 2015. The previous period was -$123.41 million in 2023.

What is iRhythm Technologies's operating income?

iRhythm Technologies's total operating income in 2024 was -$115.51 million, based on the following breakdown:

Total Gross Profit: $407.53 million
Total Operating Expenses: $523.04 million

How has iRhythm Technologies revenue changed over the last 9 years?

Over the last 9 years, iRhythm Technologies' total revenue changed from $36.14 million in 2015 to $591.84 million in 2024, a change of 1,537.6%.

How much debt does iRhythm Technologies have?

iRhythm Technologies' total liabilities were at $840.54 million at the end of 2024, a 276.8% increase from 2023, and a 1,882.4% increase since 2015.

How much cash does iRhythm Technologies have?

In the past 9 years, iRhythm Technologies' cash and equivalents has ranged from $0.00 in 2017 to $419.60 million in 2024, and is currently $419.60 million as of their latest financial filing in 2024.

How has iRhythm Technologies' book value per share changed over the last 9 years?

Over the last 9 years, iRhythm Technologies' book value per share changed from -73.85 in 2015 to 2.90 in 2024, a change of -103.9%.

Remove Ads

Related Companies

This page (NASDAQ:IRTC) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Financials

Frequently Asked Questions About iRhythm Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Financials

Annual Income Statements for iRhythm Technologies

Quarterly Income Statements for iRhythm Technologies

Annual Cash Flow Statements for iRhythm Technologies

Quarterly Cash Flow Statements for iRhythm Technologies

Annual Balance Sheets for iRhythm Technologies

Quarterly Balance Sheets for iRhythm Technologies

Annual Metrics and Ratios for iRhythm Technologies

Quarterly Metrics and Ratios for iRhythm Technologies

Frequently Asked Questions About iRhythm Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools